Visual effects firm says that Disney contracted with people who stole the technologyThe company was slapped with a lawsuit on Monday by a visual effects company, which claims that its technology was misappropriated for “Beauty and the Beast,” “Guardians of the Galaxy” and Avengers:“[I]n all of the film industry and media accolades about the record-breaking success of ‘Beauty and the Beast,’ and the acclaimed cutting-edge digital MOVA Contour technology that made the film’s success possible, nowhere is it mentioned that the patented and copyright-protected MOVA Contour technology was stolen from its inventor and developer, Rearden LLC, and its owner Rearden Mova LLC,” the suit reads.Nowhere is it mentioned that although Disney had previously contracted with Rearden LLC and its controlled entities on four previous major motion pictures to use MOVA Contour and knew of a Rearden Demand Letter to one of the thieves demanding immediate return of the stolen MOVA Contour system, Disney nonetheless contracted with the thieves to use the stolen MOVA Contour system.
NYS Entity Status
NYS Filing Date
JULY 11, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - ALLEYNE DEVELOPMENT COMPANY LLC
2014 - DREAMSKYE DEVELOPMENT LLC
Around the Web
- Disney Slapped With Lawsuit Over ‘Guardians of the Galaxy,’ ‘Avengers: Age of Ultron’ Effects
By Tim Kenneally, provided by
- Monday Jul 17, 2017
- Former monk sues L’Oreal over antiaging formula
By Pat Eaton-Robb - Wednesday Aug 30, 2017
A former Roman Catholic monk has filed a federal lawsuit seeking unspecified damages against cosmetics giant L’Oreal, accusing the company of stealing patented technology in an antiaging wrinkle cream that his charity was selling to raise money for the poor. Dennis Wyrzykowski and his company, Carmel Laboratories LLC, have been joined in the lawsuit by the University of Massachusetts Medical School, which developed the technology and licensed it to Carmel in 2009. According to the lawsuit, the cream, called Easeamine, is made using technology inspired by a discovery by two UMass scientists that adenosine, a chemical compound found in the heart, can promote skin elasticity.
- Sixgill®, LLC Launches Sense 2.0
By Business Wire - Thursday Oct 12, 2017
PRESS RELEASE: Sixgill, LLC, the leader in sensor data services for governing IoE, today unveiled the next generation of its universal and highly scalable sensor data services platform, Sixgill Sense 2.0. Sense 2.0 provides vital capabilities...
- Shareholders Demand More Drastic Shifts at Nestlé
By STEPHANIE STROM - Tuesday Jun 27, 2017
The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]